BenjaminTaylorKoppMDMPH, ATSF(He/Him)

Associate Professor, Pediatrics, Emory University. Director of Pulmonary Sickle Cell Program, Childrens Healthcare of Atlanta, Co-Director CF AIR Center

Join to view full profile

Dr. Kopp is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kopp's full profile

Already have an account?

Office
1400 Tullie Rd NE
Atlanta, GA 30329
Phone+1 404-785-5437

Summary

Ben Kopp MD, is Director of the Pulmonary Sickle Cell Program at Children’s Healthcare of Atlanta and Co-Director of the CF-AIR center at Emory. The Kopp Lab focuses on host-pathogen-environment interactions that impact chronic respiratory diseases such as CF and sickle cell. Ultimately, the lab is in the process of developing novel therapeutics to allow for improved bacterial killing.

Education & Training

The Ohio State UniversityMPH, 2017
Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Pulmonology, 2009 - 2012
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2008 - 2011
Ohio State University College of MedicineClass of 2006
Miami UniversityB.A., Zoology, 2002

Certifications & Licensure

GA State Medical License 2022 - 2025
OH State Medical License 2006 - 2022
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

OSUMC Research Day Travel Award The Ohio State University, 2012
ATS Travel Award Nationwide Children's Hospital, 2011-2012
NIH Loan Repayment Award Nationwide Children's Hospital (Columbus, OH), 2010-2012
Clinical Fellow Poster Competition Winner, DHLRI Research Day The Ohio State University, 2011
Clinical Fellow Poster Competition Winner, NCH Research Week Nationwide Children's Hospital (Columbus, OH), 2011
Distinguished Clinical Fellow of the Year Davis Heart/Lung Research Institute, The Ohio State University, 2010-2011
Pediatric Departmental Award for Academic Excellence The Ohio State University, 2006
Orr Medicine Scholarship The Ohio State University, 2005
Dean’s Scholar for Undergraduate Research Miami University (Oxford, OH), 2002
Join now to see all

Clinical Trials

Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation Start of enrollment: 2010 Oct 01
Completed
Phase 2
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment Start of enrollment: 2012 Dec 01
Completed
Phase 2
Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients Start of enrollment: 2013 Mar 01
Completed
Phase 2
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation Start of enrollment: 2014 Feb 01
Completed
Phase 1
A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation Start of enrollment: 2013 May 01
Completed
Phase 3
Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Start of enrollment: 2013 Jun 01
Completed
Phase 2
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations Start of enrollment: 2016 Dec 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1679 citations
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Daniel J. Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli
Autophagy. 2021-02-08
1 citations
Elevated high-sensitivity C-reactive protein in preterm infants with pulmonary colonization with Ureaplasma.
John Thomas Meadows, Benjamin T. Kopp, Lori A Shook, Hubert O. Ballard, Don Hayes
Journal of Thoracic Disease. 2013-03-05
9 citations
Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.
Devi Jaganathan, Emanuela M Bruscia, Benjamin T Kopp
International Journal of Molecular Sciences. 2022-07-13

Journal Articles

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators Have Differential Effects on Cystic Fibrosis Macrophage Function
Benjamin Kopp, MD, Nature
Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses
Karen McCoy, Benjamin T Kopp, The Journal of Immunology

Press Mentions

Which Kids Are Most Vulnerable to Severe COVID-19?January 18th, 2022
Cleveland Clinic and CareSource Extend Contract Through End of NovemberAugust 25th, 2017
Cleveland Doctors Keep an Eye Out for Eclipse Patients (Photos)August 22nd, 2017
Join now to see all

Committees

Member, Co-Organizer, Cystic Fibrosis Translational Research Committee, Nationwide Children's Hospital 2012 - Present
Physician Liaison, Nationwide Children's Hospital, Cystic Fibrosis Foundation of Central Ohio 2009 - Present
Application Screener, The Ohio State University College of Medicine 2013 - 2014
Member, Nationwide Children's Hospital, Cystic Fibrosis Adult Transition Committee 2012 - 2013
Member, Nationwide Children's Hospital, Graduate Medical Education Committee 2012 - 2013

Professional Memberships

American Academy of Pediatrics - AAP
Fellow
American Thoracic Society - ATS
Member, Web Committee; National Online Journal Club Co-Chair
Gold Humanism Honor Society
Member
American College of Chest Physicians - ACCP
Member